COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...

The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...

Europe's medicines regulator on Friday recommended approval for Moderna's mCombriax, paving the way for it to become the first combined shot for protecting people aged 50 and older against COVID and ...

SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...

Illinois will adopt the childhood vaccine schedule recently released by the American Academy of Pediatrics, in a rejection of federal recommendations. The move is the latest example of Illinois ...

As passengers plan their travels for the new year and ensure they have the right identification for their flights, it can get confusing to understand what types of IDs work for what types of travel.

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing ...

The European Commission (EC) has signed a 4-year joint procurement contract with Danish manufacturer Bavarian Nordic to secure up to 8 million doses of the MVA-BN vaccine against mpox and smallpox.